Ulland Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$376K Hold
1,481
0.28% 59
2026
Q1
$362K Sell
1,481
-25
-2% -$5.82K 0.31% 50
2025
Q4
$312K Hold
1,506
0.25% 54
2025
Q3
$279K Hold
1,506
0.21% 56
2025
Q2
$230K Hold
1,506
0.18% 57
2025
Q1
$250K Hold
1,506
0.21% 54
2024
Q4
$218K Hold
1,506
0.14% 55
2024
Q3
$244K Buy
1,506
+150
+11% +$23.9K 0.18% 55
2024
Q2
$198K Sell
1,356
-198
-13% -$29.4K 0.14% 61
2024
Q1
$246K Sell
1,554
-245
-14% -$39K 0.2% 52
2023
Q4
$282K Hold
1,799
0.28% 43
2023
Q3
$280K Hold
1,799
0.31% 42
2023
Q2
$298K Hold
1,799
0.31% 44
2023
Q1
$279K Hold
1,799
0.33% 45
2022
Q4
$318K Hold
1,799
0.38% 41
2022
Q3
$294K Hold
1,799
0.32% 46
2022
Q2
$319K Hold
1,799
0.33% 50
2022
Q1
$319K Buy
1,799
+70
+4% +$11.9K 0.24% 53
2021
Q4
$296K Buy
+1,729
New +$283K 0.19% 61

Other funds holding JNJ

Ulland Investment Advisors's JNJ Position: Q2 2026 in Review

Ulland Investment Advisors held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 1,481 shares worth $376K. The position accounts for 0.28% of the portfolio, ranked #59.

Ulland Investment Advisors first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. 2,801 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Ulland Investment Advisors held 1,481 shares of Johnson & Johnson worth $376K as of Q2 2026.
  • Ulland Investment Advisors left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.28% of Ulland Investment Advisors's portfolio in Q2 2026, its #59 holding.
  • Ulland Investment Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • 2,801 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Ulland Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.